Biggest News Aggregation in the World
📰 Expansion Phase News

Page 2 - Expansion Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Expansion Phase. Real-time updates on events, politics, business and more.

DGAP-News: Aignostics erhält 14 Millionen Euro „Series A"-Finanzierung für Weiterentwicklung KI-gestützter Pathologie

DGAP-News: Aignostics GmbH / Schlagwort(e): Finanzierung Aignostics erhält 14 Millionen Euro „Series A“-Finanzierung für Weiterentwicklung KI-gestützter Pathologie 15.09.2022 / 09:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Aignostics erhält 14 Millio...
Ingelheim Gmb University Hospitals Products Or Services Research Activities Digital Program Investment Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

OSE Immunotherapeutics Receives First Notice of Allowance of a Patent for Use of Tedopi after Failure with PD-1 or PD-L1 Immune Checkpoint Inhibitor Treatment in HLA-A2 Positive Cancer Patients

Issued by the Japanese Patent Office A New Protection Covering Tedopi Until 2037 Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced that
United States France General Dominique Costantini Guillaume Van Renterghem Lifesci Thomas Guillot Florence Portejoie

Briones hopes more PH schools will offer face-to-face classes by January 2022

With the planned expansion of limited face-to-face classes next year, the Department of Education (DepEd) expressed optimism that more schools will be allowed to reopen their doors to their students. In a statement issued Tuesday, Dec. 28, DepEd said that Education Secretary Leonor Magtolis Brione
Metro Manila Philippines General Tanghalang Rizal Leonor Magtolis Briones Pasig City Science High School Pasci Organisation For Economic
Source: mb.com.ph

OSE Immunotherapeutics Presents First Preclinical Efficacy Data on Anti-IL-7 Receptor Antagonist OSE-127 in Acute Lymphoblastic Leukemia

At the 2021 American Society of Hematology (ASH) Annual Meeting Regulatory News: OSE Immunotherapeutics SA (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) presented the first preclinical data on
United States Sachsen Anhalt Denis Schewe Guillaume Van Renterghem Lifesci Thomas Guillot Florence Portejoie

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science